Citi Raises WCRX 2011E EPS Estimate

Citi has raised its Warner Chilcott Plc WCRX 2011E EPS by $0.15 to $3.70(+6%) vs. WCRX's revised ‘11E target of $3.60 (+3%) - $3.70 (+5%) & the Street's $3.62(+3%). “WCRX's raised its ‘11E EPS target by $0.15 based on its refinancing of its senior secured credit facilities on more attractive terms, which lowered our projected interest expense, while maintaining its other ‘11E targets,” Citi writes. “As a result, we raised our ‘12E/'13E EPS by $0.11/$0.06 to $4.02(+8%)/$3.97(-1%) vs. the Street's $3.99(+8%)/$4.39 (+9%). Our '10-13E sales/EPS CAGR's remain at -2%/+4%. We reiterate our Buy Rating & $29 PT, which assumes WCRX trades at ~7.2x our 2012E EPS of $4.02.” Warner Chilcott closed Tuesday at $22.71.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsCitiHealth CarePharmaceuticalswarner chilcott
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!